The9 Ltd reports Q2 net income $32M, +39% from prior quarter ($5.78, 0.00)
Nanyang Biologics advancing toward Nasdaq listing after RFAI cleared vote ($4.36, 0.00)
The9 Limited to Report Second Quarter 2026 Results on August 24, 2026
Powered by FactSet Research Systems Inc.